| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 95058-81-4 | Gemcitabine |
| 50mg, 100mg, 200mg, 500mg | 询价 |
| 2 | 54-05-7 | Chloroquine |
| 50mg, 100mg | 询价 |
| 3 | 871700-17-3 | GSK1120212(Trametinib) |
| 10mg, 50mg, 100mg | 询价 |
| 4 | 197855-65-5 | Z-FA-FMK |
≥98% | | 询价 |
| 5 | 329-98-6 | PMSF |
≥98% | | 询价 |
| 6 | 76684-89-4 | Loxistatin Acid(E-64C NSC694279 EP475) |
≥98% | | 询价 |
| 7 | 225120-65-0 | Cathepsin Inhibitor 1 |
≥98% | | 询价 |
| 8 | 103628-48-4 | Sumatriptan Succinate |
| 50mg, 100mg, 500mg | 询价 |
| 9 | 88321-09-9 | Aloxistatin(Loxistatin E64d,NSC-694281) |
≥98% | | 询价 |
| 10 | 603139-19-1 | Odanacatib(MK0822) |
≥98% | | 询价 |
| 11 | 1624602-30-7 | VR23 |
≥98% | | 询价 |
| 12 | 1401223-22-0 | PI-1840 |
≥98% | | 询价 |
| 13 | 34157-83-0 | Celastrol |
≥98% | | 询价 |
| 14 | 847499-27-8 | DELANZOMIB(CEP18770) |
≥98% | | 询价 |
| 15 | 935888-69-0 | Oprozomib(ONX-0912) |
≥98% | | 询价 |
| 16 | 960374-59-8 | ONX-0914(PR-957) |
≥98% | | 询价 |
| 17 | 134381-21-8 | EPOXOMICIN(BU 4061T) |
≥98% | | 询价 |
| 18 | 1072833-77-2 | Ixazomib(MLN2238) |
≥98% | | 询价 |
| 19 | 903564-48-7 | UM-164 |
≥98% | | 询价 |
| 20 | 717907-75-0 | PF-562271 |
≥98% | | 询价 |
| 21 | 714272-27-2 | Plinabulin(NPI-2358) |
≥98% | | 询价 |
| 22 | 129497-78-5 | Verteporfin(DB-00460,CL-318952,BPD-MA,BpdMA) |
≥98% | | 询价 |
| 23 | 117570-53-3 | Vadimezan(DMXAA,NSC640488,ASA404) |
≥98% | | 询价 |
| 24 | 856243-80-6 | Degrasyn(WP-1130) |
≥98% | | 询价 |
| 25 | 859212-16-1 | Bafetinib(INNO-406 NS187) |
≥98% | | 询价 |
| 26 | 778270-11-4 | GNF-2 |
≥98% | | 询价 |
| 27 | 1020172-07-9 | Rebastinib(DCC2036) |
≥98% | | 询价 |
| 28 | 260415-63-2 | PD173955 |
≥98% | | 询价 |
| 29 | 1421783-64-3 | Olverembatinib Dimesylate(GZD824) |
≥98% | | 询价 |
| 30 | 778277-15-9 | GNF-5 |
≥98% | | 询价 |
| 31 | 926037-48-1 | Radotinib(IY 5511 Supect) |
≥98% | | 询价 |
| 32 | 839706-07-9 | GNF-7 |
≥98% | | 询价 |
| 33 | 1360460-82-7 | Anlotinib Dihydrochloride |
≥98% | | 询价 |
| 34 | 641571-10-0 | Nilotinib(AMN107 Tasigna) |
≥98% | | 询价 |
| 35 | 837422-57-8 | WH-4-023 |
≥98% | | 询价 |
| 36 | 330161-87-0 | SU6656 |
≥98% | | 询价 |
| 37 | 172889-26-8 | PP1 |
≥98% | | 询价 |
| 38 | 172889-27-9 | PP2(AG1879) |
≥98% | | 询价 |
| 39 | 897016-82-9 | Tirbanibulin(KX2391 KX-O1) |
≥98% | | 询价 |
| 40 | 380843-75-4 | Bosutinib(SKI-606 Bosulif) |
≥98% | | 询价 |
| 41 | 379231-04-6 | Saracatinib(AZD0530) |
≥98% | | 询价 |
| 42 | 1073154-85-4 | Defactinib(VS6063,PF04554878) |
≥98% | | 询价 |
| 43 | 1061353-68-1 | PND-1186(VS-4718 SR-2156) |
≥98% | | 询价 |
| 44 | 717906-29-1 | PF-431396 |
≥98% | | 询价 |
| 45 | 846557-71-9 | ML385 |
| 5mg, 10mg, 25mg | 询价 |
| 46 | 939791-41-0 | PF-562271 HCl |
≥98% | | 询价 |
| 47 | 761437-28-9 | TAE226(NVP-TAE226) |
≥98% | | 询价 |
| 48 | 869288-64-2 | PF-573228 |
≥98% | | 询价 |
| 49 | 1025687-58-4 | Fostamatinib Disodium(R788 Tavalisse) |
≥98% | | 询价 |
| 50 | 939791-38-5 | PF-00562271 Besylate |
≥98% | | 询价 |
| 51 | 1229208-44-9 | Entospletinib(GS9973) |
≥98% | | 询价 |
| 52 | 10083-24-6 | Piceatannol(Astringenin NSC-622471 trans-Piceatannol) |
≥98% | | 询价 |
| 53 | 901119-35-5 | Fostamatinib(R788 Tavalisse) |
≥98% | | 询价 |
| 54 | 1370261-97-4 | PRT062607(P505-15,BIIB057)HCl |
≥98% | | 询价 |
| 55 | 841290-80-0 | Tamatinib(R-406) |
≥98% | | 询价 |
| 56 | 1351635-67-0 | ONO-4059 analogue |
≥98% | | 询价 |
| 57 | 1242156-23-5 | RN486 |
≥98% | | 询价 |
| 58 | 332013-26-0 | Telatinib mesylate(Bay 57-9352 mesylate) |
≥98% | | 询价 |
| 59 | 1708971-55-4 | Roblitinib(FGF 401) |
≥98% | | 询价 |
| 60 | 183321-74-6 | Erlotinib(OSI744,Tarceva) |
≥98% | | 询价 |
m.cnreagent.com